Kristeleit, R; Shapiro, GI; Burris, HA; Oza, AM; LoRusso, P; Patel, MR; Domchek, SM; ... Shapira-Frommer, R; + view all Kristeleit, R; Shapiro, GI; Burris, HA; Oza, AM; LoRusso, P; Patel, MR; Domchek, SM; Balmana, J; Drew, Y; Chen, L-M; Safra, T; Montes, A; Giordano, H; Maloney, L; Goble, S; Isaacson, J; Xiao, J; Borrow, J; Rolfe, L; Shapira-Frommer, R; - view fewer (2017) A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors. Clinical Cancer Research , 23 (15) pp. 4095-4106. 10.1158/1078-0432.CCR-16-2796.